Portage Biotech
PRTG
#10206
Rank
S$19.6 M
Marketcap
Country
S$8.60
Share price
-2.16%
Change (1 day)
49.46%
Change (1 year)

Earnings for Portage Biotech (PRTG)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Portage Biotech's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.22 Billion a decrease over its 2022 earnings that were of -S$21.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Portage Biotech from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 Billion-51.34%
2023 -S$0.22 Billion891.76%
2022 -S$21.56 Million-18.44%
2021 -S$26.44 Million348.58%
2020 -S$5.9 Million-39.96%
2019 -S$9.82 Million-106.26%
2018 S$0.15 B-621.51%
2017 -S$30.08 Million-213.76%
2016 S$26.43 M-336.72%
2015 -S$11.17 Million81.72%
2014 -S$6.15 Million-4.91%
2013 -S$6.47 Million
2007 -S$0.02 Million-101.23%
2006 S$1.15 M-116.89%
2005 -S$6.87 Million264.28%
2004 -S$1.89 Million650.8%
2003 -S$0.26 Million-54.15%
2002 -S$0.55 Million11.37%
2001 -S$0.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-S$2.74 Million-97.24% Bahamas
NRC Health
NRC
S$34.83 M-135.25%๐Ÿ‡บ๐Ÿ‡ธ USA